XML 50 R22.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Segment Information | Segment Information We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. We report our business under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes our United States distribution business (Medical Distribution), outsourced logistics and value-added services business, and Global Products which manufactures and sources medical surgical products through our production and kitting operations. The Patient Direct segment includes our home healthcare businesses (Byram and Apria). We evaluate the performance of our segments based on their operating income excluding intangible amortization and acquisition-related and exit and realignment charges that, either as a result of their nature or size, would not be expected to occur as part of our normal business operations on a regular basis. Segment assets exclude inter-segment account balances as we believe their inclusion would be misleading and not meaningful. The following tables present financial information by segment:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Net revenue: |  |  |  |  |  |  |
Products & Healthcare Services | $ | 1,903,356 |  |  | $ | 2,256,295 |  |  | $ | 5,964,784 |  |  | $ | 6,621,560 |
Patient Direct | 594,045 |  |  | 245,880 |  |  | 1,439,584 |  |  | 696,609 |
Consolidated net revenue | $ | 2,497,401 |  |  | $ | 2,502,175 |  |  | $ | 7,404,368 |  |  | $ | 7,318,169 |
Operating income: |  |  |  |  |  |  |
Products & Healthcare Services | $ | 23,781 |  |  | $ | 64,415 |  |  | $ | 174,108 |  |  | $ | 316,062 |
Patient Direct | 59,666 |  |  | 14,865 |  |  | 127,791 |  |  | 41,434 |
Intangible amortization | (14,302) |  |  | (10,025) |  |  | (55,459) |  |  | (30,077) |
Acquisition-related and exit and realignment charges | (8,898) |  |  | (6,380) |  |  | (50,048) |  |  | (20,967) |
Consolidated operating income | $ | 60,247 |  |  | $ | 62,875 |  |  | $ | 196,392 |  |  | $ | 306,452 |
Depreciation and amortization: |  |  |  |  |  |  |
Products & Healthcare Services | $ | 19,121 |  |  | $ | 18,868 |  |  | $ | 57,325 |  |  | $ | 56,874 |
Patient Direct | 39,030 |  |  | 3,774 |  |  | 98,113 |  |  | 11,268 |
Consolidated depreciation and amortization | $ | 58,151 |  |  | $ | 22,642 |  |  | $ | 155,438 |  |  | $ | 68,142 |
Capital expenditures: |  |  |  |  |  |  |
Products & Healthcare Services | $ | 9,743 |  |  | $ | 13,498 |  |  | $ | 38,804 |  |  | $ | 31,768 |
Patient Direct | 39,706 |  |  | 446 |  |  | 76,344 |  |  | 857 |
Consolidated capital expenditures | $ | 49,449 |  |  | $ | 13,944 |  |  | $ | 115,148 |  |  | $ | 32,625 |
| September 30, 2022 |  | December 31, 2021
Total assets: |  |  |
Products & Healthcare Services | $ | 2,952,570 |  |  | $ | 3,012,303 |
Patient Direct | 2,509,242 |  |  | 468,536 |
Segment assets | 5,461,812 |  |  | 3,480,839 |
Cash and cash equivalents | 76,770 |  |  | 55,712 |
Consolidated total assets | $ | 5,538,582 |  |  | $ | 3,536,551 |
The following table presents net revenue by geographic area, which were attributed based on the location from which we ship products or provide services:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Net revenue: |  |  |  |  |  |  |
United States | $ | 2,410,790 |  |  | $ | 2,380,794 |  |  | $ | 7,049,382 |  |  | $ | 6,900,222 |
International | 86,611 |  |  | 121,381 |  |  | 354,986 |  |  | 417,947 |
Consolidated net revenue | $ | 2,497,401 |  |  | $ | 2,502,175 |  |  | $ | 7,404,368 |  |  | $ | 7,318,169 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration